Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cyst Fibros ; 16(3): 346-352, 2017 May.
Article in English | MEDLINE | ID: mdl-27836448

ABSTRACT

BACKGROUND: Early antimicrobial chemotherapy can prevent or at least delay chronic cystic fibrosis (CF) airways infections with Pseudomonas aeruginosa. METHODS: During a 10-year study period P. aeruginosa was detected for the first time in 54 CF patients regularly seen at the CF centre Hannover. Amplicon sequencing of 34 loci of the P. aeruginosa core genome was performed in baseline and post-treatment isolates of the 15 CF patients who had remained P. aeruginosa - positive after the first round of antipseudomonal chemotherapy. RESULTS: Deep sequencing uncovered coexisting alternative nucleotides at in total 33 of 55,284 examined genome positions including six non-synonymous polymorphisms in the lasR gene, a key regulator of quorum sensing. After early treatment 42 of 50 novel nucleotide substitutions had emerged in exopolysaccharide biosynthesis, efflux pump and porin genes. CONCLUSIONS: Early treatment selects pathoadaptive mutations in P. aeruginosa that are typical for chronic infections of CF lungs.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Proteins , Cystic Fibrosis , Pseudomonas Infections , Pseudomonas aeruginosa , Bacterial Proteins/classification , Bacterial Proteins/genetics , Bacterial Typing Techniques/methods , Child , Chronic Disease , Cystic Fibrosis/complications , Cystic Fibrosis/diagnosis , Cystic Fibrosis/epidemiology , Cystic Fibrosis/microbiology , Drug Monitoring/methods , Female , Germany/epidemiology , Humans , Infant , Male , Multilocus Sequence Typing/methods , Pseudomonas Infections/diagnosis , Pseudomonas Infections/etiology , Pseudomonas Infections/physiopathology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/physiology , Time-to-Treatment , Young Adult
2.
Antimicrob Agents Chemother ; 60(11): 6726-6734, 2016 11.
Article in English | MEDLINE | ID: mdl-27572404

ABSTRACT

The chronic airway infections with Pseudomonas aeruginosa in people with cystic fibrosis (CF) are treated with aerosolized antibiotics, oral fluoroquinolones, and/or intravenous combination therapy with aminoglycosides and ß-lactam antibiotics. An international strain collection of 361 P. aeruginosa isolates from 258 CF patients seen at 30 CF clinics was examined for mutations in 17 antimicrobial susceptibility and resistance loci that had been identified as hot spots of mutation by genome sequencing of serial isolates from a single CF clinic. Combinatorial amplicon sequencing of pooled PCR products identified 1,112 sequence variants that were not present in the genomes of representative strains of the 20 most common clones of the global P. aeruginosa population. A high frequency of singular coding variants was seen in spuE, mexA, gyrA, rpoB, fusA1, mexZ, mexY, oprD, ampD, parR, parS, and envZ (amgS), reflecting the pressure upon P. aeruginosa in lungs of CF patients to generate novel protein variants. The proportion of nonneutral amino acid exchanges was high. Of the 17 loci, mexA, mexZ, and pagL were most frequently affected by independent stop mutations. Private and de novo mutations seem to play a pivotal role in the response of P. aeruginosa populations to the antimicrobial load and the individual CF host.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Genes, Bacterial , Genetic Loci , Genome, Bacterial , Mutation , Pseudomonas aeruginosa/genetics , Amino Acid Sequence , Amino Acid Substitution , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Clone Cells , Cystic Fibrosis/drug therapy , Cystic Fibrosis/microbiology , Cystic Fibrosis/pathology , High-Throughput Nucleotide Sequencing , Humans , Microbial Sensitivity Tests , Molecular Epidemiology , Protein Conformation, alpha-Helical , Protein Interaction Domains and Motifs , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Pseudomonas Infections/pathology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/metabolism , Respiratory System/drug effects , Respiratory System/microbiology , Respiratory System/pathology , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...